| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 4 | 0 | 0 | 4 |
| Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
| Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
| Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
| Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
| Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
| Chain A, Beta-lactamase | 4 | 0 | 0 | 4 |
| Chain A, Endochitinase | 0 | 1 | 0 | 1 |
| Chain A, Endochitinase | 0 | 1 | 0 | 1 |
| Chain A, Endochitinase | 0 | 1 | 0 | 1 |
| Chain A, Class Iii Chitinase Chia1 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase II | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Chain B, Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| thioredoxin reductase | 5 | 0 | 0 | 5 |
| GALC protein | 2 | 0 | 0 | 2 |
| GLI family zinc finger 3 | 13 | 0 | 0 | 13 |
| nuclear receptor subfamily 1, group I, member 3 | 6 | 0 | 0 | 6 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 7 | 0 | 0 | 7 |
| glucocorticoid receptor [Homo sapiens] | 15 | 0 | 0 | 15 |
| retinoic acid nuclear receptor alpha variant 1 | 15 | 0 | 0 | 15 |
| retinoid X nuclear receptor alpha | 9 | 0 | 0 | 9 |
| estrogen-related nuclear receptor alpha | 14 | 0 | 0 | 14 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| arylsulfatase A | 1 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| euchromatic histone-lysine N-methyltransferase 2 | 11 | 0 | 0 | 11 |
| Bloom syndrome protein isoform 1 | 3 | 0 | 0 | 3 |
| thyroid hormone receptor beta isoform a | 3 | 0 | 0 | 3 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 13 | 0 | 0 | 13 |
| geminin | 11 | 0 | 0 | 11 |
| peripheral myelin protein 22 | 4 | 0 | 0 | 4 |
| survival motor neuron protein isoform d | 2 | 0 | 0 | 2 |
| muscleblind-like protein 1 isoform 1 | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | 4 | 1 | 0 | 5 |
| ATP-binding cassette sub-family C member 3 | 0 | 11 | 0 | 11 |
| Multidrug resistance-associated protein 4 | 0 | 11 | 0 | 13 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 4 | 0 | 4 |
| Carbonic anhydrase 12 | 0 | 2 | 1 | 5 |
| Prolyl endopeptidase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase-related protein 11 | 0 | 1 | 0 | 2 |
| Bile salt export pump | 0 | 13 | 0 | 13 |
| Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
| Renin | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 1 | 0 | 6 | 1 | 11 |
| Carbonic anhydrase 2 | 0 | 6 | 1 | 10 |
| Carbonic anhydrase 2 | 0 | 2 | 0 | 2 |
| Cytochrome P450 1A2 | 0 | 2 | 0 | 3 |
| Carbonic anhydrase 3 | 0 | 2 | 1 | 5 |
| Cathepsin B | 0 | 1 | 0 | 1 |
| Cytochrome P450 3A4 | 0 | 5 | 1 | 8 |
| Steryl-sulfatase | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2C | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C8 | 0 | 2 | 0 | 2 |
| Cytochrome P450 2D6 | 0 | 2 | 0 | 2 |
| Cytochrome P450 2A6 | 0 | 2 | 0 | 2 |
| Cytochrome P450 2C9 | 0 | 5 | 0 | 6 |
| 5-hydroxytryptamine receptor 2A | 0 | 3 | 0 | 3 |
| Androgen receptor | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 4 | 1 | 0 | 5 |
| Translocator protein | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | 4 | 1 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 4 | 1 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 4 | 1 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 4 | 1 | 0 | 5 |
| Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
| Arachidonate 5-lipoxygenase-activating protein | 0 | 1 | 0 | 1 |
| Cytochrome P450 2B6 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 4 | 0 | 2 | 1 | 4 |
| Carbonic anhydrase 6 | 0 | 2 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 4 | 1 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 4 | 1 | 0 | 5 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 4 | 0 | 4 |
| Serum paraoxonase/arylesterase 1 | 0 | 2 | 0 | 2 |
| Dipeptidyl peptidase 4 | 0 | 1 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 4 | 1 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 4 | 1 | 0 | 5 |
| Endochitinase | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 4 | 1 | 0 | 5 |
| Adenosine receptor A2a | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
| Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
| Delta-type opioid receptor | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C19 | 0 | 3 | 0 | 3 |
| Delta-type opioid receptor | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 2 | 1 | 5 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| Kappa-type opioid receptor | 0 | 1 | 1 | 2 |
| Carbonic anhydrase 7 | 0 | 2 | 1 | 4 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| D(1A) dopamine receptor | 0 | 1 | 0 | 1 |
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| D(2) dopamine receptor | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 4 | 2 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 4 | 1 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 4 | 1 | 0 | 5 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 2 | 0 | 2 |
| Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
| Beta-carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 3 | 1 | 4 |
| Squalene synthase | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 9 | 0 | 2 | 1 | 5 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase, alpha family | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 2 |
| Carbonic anhydrase | 0 | 1 | 0 | 2 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Sigma intracellular receptor 2 | 0 | 2 | 0 | 2 |
| Delta carbonic anhydrase | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
| Renin | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Endochitinase A1 | 0 | 1 | 0 | 1 |
| Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 2 | 1 | 4 |
| GABA theta subunit | 4 | 1 | 0 | 5 |
| Canalicular multispecific organic anion transporter 1 | 0 | 11 | 0 | 11 |
| Carbonic anhydrase 4 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 15 | 0 | 1 | 0 | 2 |
| Acidic mammalian chitinase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 2 | 0 | 3 |
| Carbonic anhydrase 7 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | 4 | 1 | 0 | 5 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 14 | 0 | 2 | 1 | 5 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 2, isoform A | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 2 | 1 | 5 |
| Chain A, Heat Shock Protein 90 | 0 | 0 | 1 | 1 |
| Chain A, GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE | 0 | 0 | 1 | 1 |
| Chain B, GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE | 0 | 0 | 1 | 1 |
| Chain A, EOSINOPHIL-DERIVED NEUROTOXIN | 0 | 1 | 0 | 1 |
| Chain A, EOSINOPHIL-DERIVED NEUROTOXIN | 0 | 1 | 0 | 1 |
| Chain A, EOSINOPHIL-DERIVED NEUROTOXIN | 0 | 1 | 0 | 1 |
| Chain A, Myosin Ie Heavy Chain | 0 | 0 | 1 | 1 |
| Chain A, Preprotein translocase secA | 0 | 0 | 1 | 1 |
| Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
| Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
| Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
| Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
| Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
| Chain A, Phosphoribosylformylglycinamidine synthase | 0 | 1 | 0 | 1 |
| Chain A, nucleoside diphosphate kinase A | 0 | 0 | 1 | 1 |
| Chain B, nucleoside diphosphate kinase A | 0 | 0 | 1 | 1 |
| Chain D, DNA polymerase III subunit gamma | 0 | 0 | 1 | 1 |
| Chain D, DNA polymerase III subunit gamma | 0 | 0 | 1 | 1 |
| Chain A [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 3 | 0 | 0 | 1 | 1 |
| Chain A [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 3 | 0 | 0 | 1 | 1 |
| Chain A, Kinesin-like protein KIF11 | 0 | 1 | 0 | 1 |
| regulator of G-protein signaling 4 | 3 | 0 | 0 | 3 |
| HPr kinase/phosphorylase | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 7 | 0 | 0 | 1 | 1 |
| ATP-dependent molecular chaperone HSP82 | 0 | 0 | 0 | 1 |
| Heat shock protein HSP 90-alpha | 0 | 1 | 1 | 3 |
| Heat shock protein HSP 90-beta | 0 | 1 | 1 | 3 |
| 2-dehydropantoate 2-reductase | 0 | 1 | 1 | 2 |
| Heat shock 70 kDa protein 1A | 0 | 1 | 1 | 2 |
| Endoplasmic reticulum chaperone BiP | 0 | 0 | 1 | 1 |
| Heat shock cognate 71 kDa protein | 0 | 0 | 1 | 1 |
| Pyruvate kinase PKM | 0 | 0 | 0 | 1 |
| Pyruvate kinase PKLR | 0 | 0 | 0 | 1 |
| Endoplasmin | 0 | 0 | 0 | 1 |
| Heat shock cognate 71 kDa protein | 0 | 0 | 1 | 1 |
| 5'-nucleotidase | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 0 | 1 | 1 |
| Delta-type opioid receptor | 0 | 0 | 1 | 1 |
| Kappa-type opioid receptor | 0 | 0 | 1 | 1 |
| Endoplasmin | 0 | 1 | 1 | 2 |
| P2Y purinoceptor 2 | 0 | 0 | 1 | 1 |
| Phosphatidylinositol 4-kinase alpha | 0 | 2 | 0 | 2 |
| P2X purinoceptor 1 | 0 | 0 | 1 | 1 |
| P2Y purinoceptor 1 | 0 | 0 | 1 | 1 |
| P2Y purinoceptor 1 | 0 | 0 | 1 | 1 |
| P2X purinoceptor 1 | 0 | 0 | 1 | 1 |
| P2X purinoceptor 4 | 0 | 0 | 1 | 1 |
| P2X purinoceptor 5 | 0 | 0 | 1 | 1 |
| P2X purinoceptor 6 | 0 | 0 | 1 | 1 |
| P2X purinoceptor 3 | 0 | 0 | 1 | 1 |
| Inositol monophosphatase 1 | 1 | 0 | 0 | 1 |
| Heat shock protein 75 kDa, mitochondrial | 0 | 1 | 0 | 1 |
| P2Y purinoceptor 6 | 0 | 0 | 1 | 1 |
| Phosphatidylinositol 4-kinase type 2-beta | 0 | 2 | 0 | 2 |
| P2Y purinoceptor 11 | 0 | 0 | 1 | 1 |
| Phosphatidylinositol 4-kinase type 2-alpha | 0 | 2 | 0 | 2 |
| P2Y purinoceptor 12 | 0 | 1 | 1 | 2 |
| Sensor protein kinase WalK | 0 | 1 | 0 | 1 |
| Phosphatidylinositol 4-kinase beta | 0 | 2 | 0 | 2 |
| P2X purinoceptor 2 | 0 | 0 | 1 | 1 |
| TDP1 protein | 10 | 0 | 0 | 10 |
| AR protein | 16 | 0 | 0 | 16 |
| estrogen nuclear receptor alpha | 19 | 0 | 0 | 19 |
| peroxisome proliferator activated receptor gamma | 6 | 0 | 0 | 6 |
| Cellular tumor antigen p53 | 9 | 0 | 0 | 9 |
| Thromboxane-A synthase | 0 | 2 | 0 | 2 |
| Prostaglandin E2 receptor EP3 subtype | 0 | 3 | 0 | 3 |
| Prostaglandin E2 receptor EP4 subtype | 0 | 3 | 1 | 4 |
| Prostaglandin E2 receptor EP1 subtype | 0 | 3 | 0 | 3 |
| Prostacyclin receptor | 0 | 3 | 2 | 5 |
| Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 0 | 0 | 2 |
| Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
| Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
| Prostaglandin E2 receptor EP2 subtype | 0 | 3 | 1 | 4 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 0 | 0 | 2 |
| Solute carrier organic anion transporter family member 2B1 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 3A1 | 0 | 0 | 0 | 1 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 7 | 0 | 0 | 7 |
| Chain A, Mutant Al2 6e7p9g | 0 | 0 | 1 | 1 |
| Chain A, 2-oxoglutarate Oxygenase | 5 | 0 | 0 | 5 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
| Chain A, Cruzipain | 4 | 0 | 0 | 4 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| acid sphingomyelinase | 1 | 0 | 0 | 1 |
| GLS protein | 5 | 0 | 0 | 5 |
| apical membrane antigen 1, AMA1 | 2 | 0 | 0 | 2 |
| farnesoid X nuclear receptor | 5 | 0 | 0 | 5 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Metallo-beta-lactamase type 2 | 0 | 0 | 0 | 1 |
| Metallo-beta-lactamase VIM-11 | 0 | 0 | 0 | 1 |
| Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Metallo-beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 3 | 0 | 0 | 3 |
| chromobox protein homolog 1 | 6 | 0 | 0 | 6 |
| thyroid hormone receptor beta isoform 2 | 10 | 0 | 0 | 10 |
| DNA polymerase beta | 1 | 0 | 0 | 1 |
| DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
| DNA polymerase iota isoform a (long) | 6 | 0 | 0 | 6 |
| DNA polymerase kappa isoform 1 | 3 | 0 | 0 | 3 |
| 60 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
| Beta-lactamase OXA-7 | 0 | 0 | 0 | 1 |
| Solute carrier family 15 member 1 | 0 | 2 | 0 | 2 |
| Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
| Spike glycoprotein | 3 | 0 | 0 | 3 |
| 10 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
| Angiopoietin-1 receptor | 0 | 0 | 1 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Solute carrier family 15 member 2 | 0 | 1 | 0 | 1 |
| Thiosulfate sulfurtransferase | 0 | 1 | 0 | 1 |
| Metallo-beta-lactamase VIM-13 | 0 | 1 | 0 | 2 |
| Efflux transporter | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase Toho-1 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Class D beta-lactamase | 0 | 0 | 0 | 1 |
| 60 kDa chaperonin | 0 | 1 | 0 | 1 |
| Metallo-beta-lactamase | 0 | 0 | 0 | 1 |
| Solute carrier family 15 member 2 | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| 10 kDa chaperonin | 0 | 1 | 0 | 1 |
| Metallo-b-lactamase | 0 | 0 | 0 | 1 |
| Carbapenem-hydrolyzing beta-lactamase KPC | 0 | 0 | 0 | 1 |
| Histamine H3 receptor | 0 | 0 | 0 | 1 |
| Beta-lactamase class B VIM-2 | 0 | 0 | 0 | 1 |
| Beta-lactamase VIM-1 | 0 | 1 | 0 | 2 |
| ATP-dependent phosphofructokinase | 3 | 0 | 0 | 3 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| phosphopantetheinyl transferase | 4 | 0 | 0 | 4 |
| NFKB1 protein, partial | 2 | 0 | 0 | 2 |
| thyroid stimulating hormone receptor | 7 | 0 | 0 | 7 |
| alpha-galactosidase | 1 | 0 | 0 | 1 |
| cytochrome P450 2C19 precursor | 2 | 0 | 0 | 2 |
| flap endonuclease 1 | 2 | 0 | 0 | 2 |
| muscarinic acetylcholine receptor M1 | 4 | 0 | 0 | 4 |
| lethal factor (plasmid) | 7 | 0 | 0 | 7 |
| Nitric oxide synthase, endothelial | 0 | 0 | 0 | 2 |
| Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, inducible | 0 | 1 | 0 | 2 |
| Nitric oxide synthase, inducible | 0 | 0 | 1 | 3 |
| Cationic amino acid transporter 3 | 0 | 1 | 0 | 1 |
| Chain A, Hyaluronidase, phage associated | 0 | 1 | 0 | 1 |
| acetylcholinesterase | 4 | 0 | 0 | 4 |
| RAR-related orphan receptor gamma | 10 | 0 | 0 | 10 |
| thioredoxin glutathione reductase | 3 | 0 | 0 | 3 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 6 | 0 | 0 | 6 |
| IDH1 | 2 | 0 | 0 | 2 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 3 | 0 | 0 | 3 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
| lamin isoform A-delta10 | 4 | 0 | 0 | 4 |
| Polyphenol oxidase 2 | 0 | 2 | 0 | 2 |
| Pancreatic alpha-amylase | 0 | 2 | 0 | 2 |
| Albumin | 0 | 1 | 0 | 1 |
| Urease | 0 | 1 | 0 | 1 |
| Prolyl 4-hydroxylase subunit alpha-1 | 0 | 0 | 0 | 1 |
| Tyrosinase | 0 | 1 | 0 | 1 |
| Alpha-2B adrenergic receptor | 0 | 0 | 1 | 1 |
| Hyaluronate lyase | 0 | 1 | 0 | 1 |
| Prolyl hydroxylase EGLN2 | 0 | 0 | 0 | 1 |
| Egl nine homolog 1 | 0 | 0 | 0 | 1 |
| Prolyl hydroxylase EGLN3 | 0 | 0 | 0 | 1 |
| Hypoxia-inducible factor 1-alpha inhibitor | 0 | 0 | 0 | 1 |
| Solute carrier family 23 member 1 | 0 | 1 | 0 | 1 |
| Chain A, Phospholipase A2 isoform 3 | 0 | 0 | 1 | 1 |
| Chain A, HADH2 protein | 4 | 0 | 0 | 4 |
| Chain B, HADH2 protein | 4 | 0 | 0 | 4 |
| GTP-binding protein (rab7) | 0 | 0 | 1 | 1 |
| ras protein, partial | 0 | 0 | 1 | 1 |
| interleukin 8 | 6 | 0 | 0 | 6 |
| aldehyde dehydrogenase 1 family, member A1 | 7 | 0 | 0 | 7 |
| hypothetical protein, conserved | 1 | 0 | 0 | 1 |
| EWS/FLI fusion protein | 4 | 0 | 0 | 4 |
| cytochrome P450 2D6 | 1 | 0 | 0 | 1 |
| glucocerebrosidase | 2 | 0 | 0 | 2 |
| peroxisome proliferator-activated receptor delta | 5 | 0 | 0 | 5 |
| Rac1 protein | 0 | 0 | 1 | 1 |
| cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 1 | 1 |
| Prostaglandin-H2 D-isomerase | 0 | 2 | 0 | 2 |
| Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 4 |
| Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 3 |
| Epidermal growth factor receptor | 0 | 2 | 0 | 2 |
| Fatty acid-binding protein, liver | 0 | 2 | 0 | 2 |
| Integrin beta-3 | 0 | 1 | 0 | 1 |
| Myeloperoxidase | 0 | 2 | 0 | 2 |
| Prostaglandin G/H synthase 1 | 0 | 4 | 0 | 5 |
| Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 1 |
| Integrin alpha-IIb | 0 | 1 | 0 | 1 |
| Glutathione hydrolase 1 proenzyme | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 4 | 0 | 4 |
| Substance-P receptor | 0 | 2 | 0 | 2 |
| Prostaglandin G/H synthase 2 | 0 | 6 | 1 | 7 |
| Urotensin-2 receptor | 0 | 1 | 0 | 1 |
| 4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 0 | 1 |
| Nuclear receptor ROR-gamma | 4 | 0 | 0 | 4 |
| Ras-related protein Rab-2A | 0 | 0 | 1 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 4 | 0 | 4 |
| Rho-associated protein kinase 2 | 0 | 2 | 0 | 2 |
| Nicotinate phosphoribosyltransferase | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 20 | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
| Sigma non-opioid intracellular receptor 1 | 0 | 0 | 1 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 0 | 1 | 1 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 1 | 0 | 0 | 1 |
| 15-lipoxygenase, partial | 2 | 0 | 0 | 2 |
| pregnane X nuclear receptor | 8 | 0 | 0 | 8 |
| aryl hydrocarbon receptor | 7 | 0 | 0 | 7 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 3 | 0 | 0 | 3 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 3 | 0 | 0 | 3 |
| Matrix metalloproteinase-9 | 0 | 1 | 0 | 1 |
| Disintegrin and metalloproteinase domain-containing protein 17 | 2 | 0 | 0 | 2 |
| Chain A, Vitamin D Nuclear Receptor | 0 | 0 | 1 | 1 |
| Chain A, Ferritin light chain | 2 | 0 | 0 | 2 |
| Vitamin D3 receptor | 0 | 0 | 1 | 1 |
| USP1 protein, partial | 2 | 0 | 0 | 2 |
| PPM1D protein | 1 | 0 | 0 | 1 |
| Microtubule-associated protein tau | 4 | 0 | 0 | 4 |
| mitogen-activated protein kinase 1 | 3 | 0 | 0 | 3 |
| nuclear receptor ROR-gamma isoform 1 | 6 | 0 | 0 | 6 |
| Interferon beta | 4 | 0 | 0 | 4 |
| Vitamin D-binding protein | 0 | 0 | 1 | 1 |
| Androgen receptor | 0 | 3 | 1 | 4 |
| Vitamin D3 receptor | 0 | 1 | 2 | 4 |
| Vitamin D3 receptor | 0 | 1 | 1 | 3 |
| Retinoic acid receptor RXR-alpha | 0 | 0 | 1 | 1 |
| Vitamin D3 receptor | 0 | 0 | 1 | 1 |
| 1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial | 0 | 0 | 1 | 1 |
| Vitamin D3 receptor | 0 | 1 | 1 | 2 |
| Transporter | 0 | 1 | 0 | 1 |
| Vitamin D3 receptor A | 0 | 0 | 2 | 2 |
| endonuclease IV | 2 | 0 | 0 | 2 |
| dopamine D1 receptor | 2 | 0 | 0 | 2 |
| pregnane X receptor | 5 | 0 | 0 | 5 |
| progesterone receptor | 10 | 0 | 0 | 10 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 5 | 0 | 0 | 5 |
| peripheral myelin protein 22 isoform 1 | 2 | 0 | 0 | 2 |
| atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
| heat shock protein beta-1 | 3 | 0 | 0 | 3 |
| cytochrome P450 3A4 isoform 1 | 4 | 0 | 0 | 4 |
| M-phase phosphoprotein 8 | 2 | 0 | 0 | 2 |
| Glucocorticoid receptor | 0 | 6 | 2 | 13 |
| Sex hormone-binding globulin | 0 | 0 | 1 | 1 |
| Glycine receptor subunit alpha-1 | 0 | 6 | 0 | 6 |
| Corticosteroid-binding globulin | 0 | 2 | 0 | 2 |
| Glycine receptor subunit beta | 0 | 6 | 0 | 6 |
| Glycine receptor subunit alpha-2 | 0 | 6 | 0 | 6 |
| Glycine receptor subunit alpha-3 | 0 | 6 | 0 | 6 |
| Potassium voltage-gated channel subfamily A member 1 | 0 | 0 | 1 | 1 |
| TAR DNA-binding protein 43 | 2 | 0 | 0 | 2 |
| Multidrug and toxin extrusion protein 1 | 0 | 2 | 0 | 2 |
| SMAD family member 2 | 5 | 0 | 0 | 5 |
| SMAD family member 3 | 5 | 0 | 0 | 5 |
| thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
| activating transcription factor 6 | 4 | 0 | 0 | 4 |
| prostaglandin E2 receptor EP2 subtype | 1 | 0 | 0 | 1 |
| vitamin D3 receptor isoform VDRA | 5 | 0 | 0 | 5 |
| Solute carrier family 22 member 2 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 1 | 0 | 1 | 0 | 2 |
| Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 1 |
| Prostaglandin E2 receptor EP1 subtype | 0 | 2 | 1 | 3 |
| Prostaglandin E2 receptor EP4 subtype | 0 | 2 | 1 | 3 |
| Prostaglandin F2-alpha receptor | 0 | 0 | 1 | 1 |
| Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 1 | 2 |
| Prostaglandin E2 receptor EP3 subtype | 0 | 2 | 1 | 3 |
| Prostaglandin E2 receptor EP2 subtype | 0 | 2 | 1 | 3 |
| Solute carrier family 22 member 6 | 0 | 2 | 0 | 4 |
| Solute carrier family 22 member 7 | 0 | 0 | 0 | 2 |
| Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 1 | 2 |
| Solute carrier family 22 member 8 | 0 | 2 | 0 | 3 |
| Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 11 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B2 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
| hypoxia-inducible factor 1 alpha subunit | 4 | 0 | 0 | 4 |
| Histone H2A.x | 1 | 0 | 0 | 1 |
| Eyes absent homolog 2 | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 2 | 0 | 0 | 2 |
| Voltage-dependent calcium channel gamma-2 subunit | 5 | 0 | 0 | 5 |
| Amyloid-beta precursor protein | 0 | 2 | 0 | 2 |
| Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
| Glutamate receptor 2 | 5 | 0 | 0 | 5 |
| Histamine H2 receptor | 3 | 0 | 0 | 3 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 6 | 0 | 0 | 6 |
| nuclear receptor subfamily 1, group I, member 2 | 2 | 0 | 0 | 2 |
| Glycine receptor subunit alpha-1 | 0 | 0 | 1 | 1 |
| Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 3 | 1 | 4 |
| Sodium- and chloride-dependent glycine transporter 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 1 | 3 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 2 | 1 | 3 |
| Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 2 | 1 | 3 |
| Proton-coupled amino acid transporter 1 | 0 | 3 | 0 | 3 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 2 | 1 | 3 |
| Serine racemase | 0 | 1 | 0 | 1 |
| Olfactory receptor 51E2 | 0 | 0 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 2 | 1 | 3 |
| Sodium- and chloride-dependent glycine transporter 2 | 0 | 1 | 0 | 1 |
| Neutral amino acid transporter A | 0 | 2 | 0 | 2 |
| Asc-type amino acid transporter 1 | 0 | 1 | 0 | 1 |
| Neutral amino acid transporter B(0) | 0 | 2 | 0 | 2 |
| Amino acid transporter | 0 | 2 | 0 | 2 |
| Chain A, membrane-associated prostaglandin E synthase-2 | 0 | 1 | 0 | 1 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 1 | 0 | 0 | 1 |
| Luciferase | 4 | 0 | 0 | 4 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 2 | 0 | 0 | 2 |
| estrogen receptor 2 (ER beta) | 5 | 0 | 0 | 5 |
| G | 1 | 0 | 0 | 1 |
| 67.9K protein | 3 | 0 | 0 | 3 |
| Parkin | 1 | 0 | 0 | 1 |
| bromodomain adjacent to zinc finger domain 2B | 2 | 0 | 0 | 2 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 2 | 0 | 0 | 2 |
| cytochrome P450 2D6 isoform 1 | 2 | 0 | 0 | 2 |
| cytochrome P450 2C9 precursor | 1 | 0 | 0 | 1 |
| ras-related protein Rab-9A | 1 | 0 | 0 | 1 |
| serine/threonine-protein kinase mTOR isoform 1 | 1 | 0 | 0 | 1 |
| neuropeptide S receptor isoform A | 1 | 0 | 0 | 1 |
| Prostaglandin E synthase | 0 | 1 | 0 | 1 |
| 3',5'-cyclic-AMP phosphodiesterase | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 2B1 | 0 | 2 | 0 | 2 |
| Cytochrome c oxidase subunit 2 | 0 | 1 | 0 | 1 |
| Phospholipase A2, major isoenzyme | 0 | 1 | 0 | 1 |
| HLA class I histocompatibility antigen, B alpha chain | 1 | 0 | 0 | 1 |
| Albumin | 0 | 1 | 1 | 2 |
| Procathepsin L | 0 | 1 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
| Interleukin-8 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-2 | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 2 | 0 | 5 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member C4 | 0 | 2 | 0 | 2 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
| Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
| Caspase-1 | 0 | 1 | 0 | 2 |
| Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
| Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 1 |
| Bifunctional epoxide hydrolase 2 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 3 |
| Peroxisome proliferator-activated receptor gamma | 0 | 0 | 1 | 1 |
| Aldo-keto reductase family 1 member C3 | 0 | 3 | 0 | 3 |
| Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
| C-X-C chemokine receptor type 3 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member C2 | 0 | 2 | 0 | 2 |
| Guanine nucleotide-binding protein G | 2 | 0 | 0 | 2 |
| Prostaglandin D2 receptor | 0 | 2 | 0 | 2 |
| Solute carrier organic anion transporter family member 1A3 | 0 | 1 | 0 | 1 |
| Lactoylglutathione lyase | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member C1 | 0 | 2 | 0 | 2 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 2 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 2 | 0 | 2 |
| Uracil nucleotide/cysteinyl leukotriene receptor | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 3 |
| Inositol hexakisphosphate kinase 1 | 1 | 0 | 0 | 1 |
| Dehydrogenase/reductase SDR family member 9 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 2 | 0 | 2 |
| Cytosolic phospholipase A2 gamma | 0 | 1 | 0 | 1 |
| Prostaglandin D2 receptor 2 | 0 | 1 | 1 | 2 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 2 | 0 | 2 |
| cytochrome P450 2C9, partial | 1 | 0 | 0 | 1 |
| histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
| 3-oxoacyl-[acyl-carrier-protein] synthase 3 | 0 | 1 | 0 | 1 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 2 | 0 | 0 | 2 |
| histone acetyltransferase KAT2A isoform 1 | 1 | 0 | 0 | 1 |
| N-glycosylase/DNA lyase | 0 | 1 | 0 | 1 |
| Bile salt export pump | 0 | 1 | 0 | 1 |
| Formamidopyrimidine-DNA glycosylase | 0 | 1 | 0 | 1 |
| DNA gyrase subunit A | 0 | 1 | 0 | 1 |
| DNA gyrase subunit B | 0 | 1 | 0 | 1 |
| Macrophage migration inhibitory factor | 0 | 1 | 0 | 1 |
| Endonuclease III-like protein 1 | 0 | 1 | 0 | 1 |
| DNA gyrase subunit B | 0 | 1 | 0 | 1 |
| DNA gyrase subunit A | 0 | 1 | 0 | 1 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 1 | 0 | 2 |
| Pantothenate synthetase | 0 | 1 | 0 | 1 |
| Isocitrate lyase | 0 | 1 | 0 | 1 |
| Putative FAD-containing monooxygenase MymA | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Endonuclease 8-like 1 | 0 | 1 | 0 | 1 |
| ATAD5 protein, partial | 2 | 0 | 0 | 2 |
| Chymotrypsinogen A | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 3 | 0 | 3 |
| Hormone-sensitive lipase | 0 | 1 | 0 | 1 |
| Caspase-3 | 0 | 1 | 0 | 1 |
| Caspase-4 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2J2 | 0 | 3 | 0 | 3 |
| Caspase-5 | 0 | 1 | 0 | 1 |
| Caspase-9 | 0 | 1 | 0 | 1 |
| luciferase | 0 | 0 | 0 | 1 |
| Estrogen receptor | 0 | 2 | 0 | 2 |
| Progesterone receptor | 0 | 2 | 0 | 3 |
| Glucocorticoid receptor | 0 | 1 | 1 | 2 |
| Glucocorticoid receptor | 0 | 0 | 1 | 1 |
| Mineralocorticoid receptor | 0 | 2 | 1 | 3 |
| Glutamine synthetase | 0 | 0 | 1 | 1 |
| Histamine H1 receptor | 0 | 0 | 1 | 1 |
| Nociceptin receptor | 0 | 0 | 1 | 1 |
| Estrogen receptor beta | 0 | 2 | 0 | 2 |
| ATPase family AAA domain-containing protein 5 | 2 | 0 | 0 | 2 |
| Ataxin-2 | 2 | 0 | 0 | 2 |
| Glutamate 5-kinase | 0 | 0 | 0 | 1 |
| glp-1 receptor, partial | 1 | 0 | 0 | 1 |
| nonstructural protein 1 | 1 | 0 | 0 | 1 |
| heat shock protein HSP 90-alpha isoform 2 | 0 | 0 | 0 | 1 |
| heat shock protein 90, putative | 0 | 0 | 0 | 1 |
| Chain A, dATP pyrophosphohydrolase | 0 | 1 | 0 | 1 |
| Chain A, Adenylate cyclase type 5 | 0 | 1 | 0 | 1 |
| Chain B, Adenylate cyclase type 2 | 0 | 1 | 0 | 1 |
| Chain A, PLASMA RETINOL-BINDING PROTEIN PRECURSOR | 0 | 0 | 1 | 1 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 1 | 0 | 0 | 1 |
| Retinol-binding protein 4 | 0 | 0 | 1 | 1 |
| Beta-lactoglobulin | 0 | 0 | 1 | 1 |
| Alpha-synuclein | 0 | 1 | 0 | 1 |
| Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
| Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
| Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
| Chain A, 146aa long hypothetical transcriptional regulator | 0 | 0 | 1 | 1 |
| Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Chain B, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Chain C, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| exodeoxyribonuclease V subunit RecD | 0 | 1 | 0 | 1 |
| exodeoxyribonuclease V subunit RecB | 0 | 1 | 0 | 1 |
| exodeoxyribonuclease V subunit RecC | 0 | 1 | 0 | 1 |
| ATP-dependent 6-phosphofructokinase | 0 | 1 | 0 | 1 |
| Dihydropteroate synthase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 3 | 0 | 4 |
| Endothelin-1 receptor | 0 | 1 | 0 | 1 |
| Protease | 0 | 1 | 1 | 2 |
| Protein-arginine deiminase type-4 | 0 | 2 | 0 | 2 |
| Chain A, Dihydrofolate Reductase | 0 | 0 | 1 | 1 |
| Chain A, Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Chain A, dihydrofolate reductase (DHFR) | 0 | 1 | 0 | 1 |
| Chain A, Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Chain A, Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 2 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Dihydrofolate reductase type 1 | 0 | 1 | 0 | 2 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 2 | 0 | 2 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| NH(3)-dependent NAD(+) synthetase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 2 | 0 | 2 |
| Dihydrofolate reductase type 1 from Tn4003 | 0 | 1 | 0 | 1 |
| Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Metabotropic glutamate receptor 5 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Trace amine-associated receptor 5 | 0 | 0 | 1 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 2 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
| Chain A, glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
| Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
| Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
| Solute carrier family 2, facilitated glucose transporter member 9 | 0 | 1 | 1 | 2 |
| Guanine deaminase | 0 | 1 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |